CMS approves coverage for Recor Medical renal denervation study
November 21, 2025
Recor Medical said today that it secured Medicare approval, granting coverage for the company’s RADIANCE CED study.
Recor Medical said today that it secured Medicare approval, granting coverage for the company’s RADIANCE CED study.
ELLSWORTH, Maine, Nov. 19, 2025 /PRNewswire/ — Rejuva Fresh®, a global leader in non-invasive aesthetic and wellness solutions, proudly announces expanded CE certification and design upgrades for its revolutionary EMSTRONG® platform, reinforcing its leadership in pelvic health and intimate wellness.
PLANO, Texas, Nov. 18, 2025 /PRNewswire/ — Vesalio, a leader in innovative thrombectomy solutions, today announced two new FDA 510(k) clearances for its aspiration devices, designed for peripheral and neurovascular applications. These clearances mark a key milestone in Vesalio’s evolution toward providing a complete suite of thrombectomy products across multiple vascular territories.
Philips (NYSE: PHG)+ today announced the introduction of DeviceGuide, an AI-powered tracking solution for interventional cardiology.
FRANKLIN LAKES, N.J., Nov. 12, 2025 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, introduces the PureWick™ Portable Collection System, a discreet, first-of-its-kind, battery-powered personal urine management device designed for wheelchair users to help improve mobility around and outside the home.
Sentante today announced the completion of a first-of-its-kind remote stroke procedure in Scotland using its robotic platform.
Launch further expands Xtant’s biologics product portfolio to include surgical wound closure
Mediplus has expanded its award-winning S-Cath System range for suprapubic catheterisation with the launch of S-Cath System Long, featuring longer components and enhanced features to give clinicians greater choice, flexibility, and improved usability.
Volta Medical has announced the U.S. launch of its AF-Xplorer II system, the company’s ‘next-generation’ AI solution which it says is designed to simplify real-time assessment of complex AF.
Microbot Medical (Nasdaq:MBOT) announced today that it began the U.S. commercial launch of its Liberty endovascular surgical robot.